Přihlásit se Zaregistrujte se zdarma

Quick ratio společnosti Midatech Pharma Plc

Jaká je hodnota metriky Quick ratio společnosti Midatech Pharma Plc?

Hodnota metriky Quick ratio společnosti Midatech Pharma Plc je 5.28

Jaká je definice metriky Quick ratio?



Quick ratio je ukazatel likvidity, který měří schopnost společnosti využít své jmění na pokrytí krátkodobých závazků.

The quick ratio is the ratio between quick or liquid assets and current liabilities. Quick assets include those current assets that presumably can be quickly converted to cash at close to their book values. A normal liquid ratio is considered to be 1. A company with a quick ratio of less than 1 cannot at the time fully pay its current liabilities or short-term obligations. This ratio is considered to be a much reliable tool for assessment of liquidity position of companies.

Quick ratio společností v sektoru Health Care sektor na LSE ve srovnání se společností Midatech Pharma Plc

Čemu se věnuje společnost Midatech Pharma Plc?

Midatech Pharma plc focuses on the research and development of oncology and rare disease products in the United Kingdom, rest of Europe, and internationally. The company is developing MTX110, a direct delivery treatment for diffuse intrinsic pontine glioma, medulloblastomas, and glioblastoma multiforme; MTX114, an immuno-suppressant for topical application in psoriasis; and MTD211 and MTD219 for central nervous system and transplant anti-rejection indications. It also offers drug delivery platforms, such as Q-Sphera, a polymer microsphere microtechnology used for sustained release drug delivery; MidaSolve, an oligosaccharide nanotechnology used to solubilize drugs so that they can be administered in liquid form directly and locally into tumors; and MidaCore, a gold nanoparticle used for targeting sites of disease by using chemotherapeutic agents or immunotherapeutic agents. The company was founded in 2000 and is headquartered in Cardiff, the United Kingdom.

Firmy s metrikou quick ratio podobnou společnosti Midatech Pharma Plc